Skip to main content
BIO-FD&C CO.,LTD. logo

BIO-FD&C CO.,LTD. — Investor Relations & Filings

Ticker · 251120 ISIN · KR7251120002 KO Manufacturing
Open in API
Filings indexed 95 across all filing types
Latest filing 2023-03-08 AGM Information
Country KR South Korea
Listing KO 251120

About BIO-FD&C CO.,LTD.

https://www.biofdnc.com/?lang=en

BIO-FD&C CO.,LTD. is a biotechnology company specializing in research and development based on a proprietary, sustainable plant cell platform technology. The company develops and commercializes high-value active ingredients for the cosmetics, pharmaceutical, and food industries. Its product portfolio includes plant cell-derived materials, bioactive recombinant proteins, growth factors, and peptides, with a significant focus on anti-aging ingredients for cosmeceuticals. Leveraging advanced techniques such as bioreactor cultivation, radiofrequency-enhanced production of bioactive compounds (SMART-RC2), and plant cell cryopreservation, the company is also exploring the development of plant cell-based therapeutics, including antibodies and vaccines.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with other companies' meetings. Since this is a regulatory notification regarding meeting logistics and does not contain the actual AGM presentation materials, proxy statements, or voting results, it falls under the general regulatory filing category.
2023-03-08 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for BioFD&C. It contains the meeting agenda, details on voting, and management information, which are standard components of a proxy solicitation document sent to shareholders to inform them of an upcoming meeting and request their participation. This aligns with the definition of a Proxy Solicitation & Information Statement.
2023-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Solicitation of Proxy Reference Document), which is a standard regulatory filing in South Korea (DART system) used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains specific agenda items such as approval of financial statements, appointment of auditors, and director remuneration limits. While it contains financial data, it is not an Annual Report (10-K) or an Earnings Release (ER), but rather a proxy solicitation document. Therefore, it fits the 'Proxy Solicitation & Information Statement' category.
2023-03-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (BioFD&C) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report preliminary financial results before the final audited annual report is published. Since it provides key financial highlights and reasons for the change, it falls under the Earnings Release (ER) category. FY 2022
2023-02-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This specific document details a change in shareholding percentage (from 8.46% to 5.47%) by a foreign entity, 'SELECT RANGE LIMITED', in the company 'BioFD&C'. This falls under the category of Major Shareholding Notification (MRQ), as it tracks significant changes in ownership levels.
2023-01-31 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status by Trust Agreement' (신탁계약등에의한취득상황보고서) filed with the Financial Supervisory Service (금융감독원). It details the company's (BioFD&C) share buyback activities conducted through a trust agreement with DB Financial Investment. This type of filing, which reports the company's purchase of its own shares, falls under the 'Transaction in Own Shares' category.
2023-01-20 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.